Study of a new imaging method for skin cancer surgery
Part of Cancer clinical trials.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be scheduled to have Mohs surgery for a type of basal cell carcinoma called superficial BCC or a mix that includes superficial BCC.
- You must be willing to sign a consent form and follow the study procedures.
- You cannot have an allergy to mineral oil, which is used during imaging.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new microscope technique that may help doctors see more clearly whether all cancer cells have been removed during standard skin cancer surgery. It could help make sure the surgery is successful the first time.
This study tests a new imaging method called LC-OCT to look at basal cell carcinoma before Mohs surgery. It may help doctors see the tumor more clearly and plan the surgery better.
This study is testing whether a special type of scan (called D-OCT) can accurately detect and classify a common type of skin cancer called basal cell carcinoma. The goal is to see if this scan can diagnose the cancer without needing a biopsy.
This study looks at how people with advanced basal cell carcinoma (a type of skin cancer that is hard to treat or has spread) are cared for and what happens over time. It does not test any new treatments, but helps doctors learn more about the disease.
This trial uses a special microscope to look at skin biopsy samples in new ways. It may help doctors understand skin conditions better without needing extra procedures.
This study is looking at how well a new skin imaging tool called LC-OCT works in everyday skin cancer clinics in the Netherlands. It will help doctors understand if this tool can accurately identify skin cancers without needing as many biopsies.
Hear when a new Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.